Meta-analysisindependent cross-checkabstract only checked I-SOD-05 standard review

Fructose and gout: meta-analysis

Fructose intake and risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies.

Overview

Jamnik J et al.. BMJ Open 2016 · PMID 27697882 · DOI 10.1136/bmjopen-2016-013191

High fructose intake was linked with 62% higher gout risk in two cohorts; certainty low.

Does the study support the specific claim? Yes · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Is fructose associated with incident gout/hyperuricaemia?

How was the study done?

Systematic review and meta-analysis of prospective cohorts with GRADE.

How many people, animals or samples were studied?

2 cohorts; 125,299; 1,533 gout cases; Predominantly white health professionals

What was actually found?

RR 1.62 (1.28-2.03), I2 0%; GRADE low (indirectness).

How large was the observed effect?

RR 1.62 (1.28-2.03)

What do the results mean in everyday life?

Fructose from any source may matter for gout.

What are the study's limitations?

Only 2 cohorts; Indirect population

What does it say about Elawady's specific claim?

Supports C-SOD-05 (with limitations).

Do the results apply to Germany and Europe?

Moderate.

What can explicitly not be concluded from this study?

Causation.

Scientific in-depth review

1. Full reference

Authors
Jamnik J et al.
Journal
BMJ Open
Year
2016
Identifier
PMID 27697882 DOI 10.1136/bmjopen-2016-013191
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

One author WHO advisory travel support; other disclosures in record

2. Research question

Is fructose associated with incident gout/hyperuricaemia?

3. Study design and population

Study design
Meta-analysis – Systematic review and meta-analysis of prospective cohorts with GRADE.
Population

Predominantly white health professionals

Country

USA

Period

Literature to Sept 2015

Sample size

2 cohorts; 125,299; 1,533 gout cases

Inclusion and exclusion criteria

Prospective cohorts

4. Methods and endpoints

Exposure / intervention

Fructose intake highest quantile

Comparator

Lowest quantile

Endpoints

Incident gout

Statistical methods

Generic inverse variance

5. Actual results

Results

RR 1.62 (1.28-2.03), I2 0%; GRADE low (indirectness).

Absolute risks

not reported

Authors' conclusion

Fructose associated with gout in white health professionals; more studies needed.

6. Strengths

  • GRADE
  • No heterogeneity

7. Weaknesses

  • Only 2 cohorts
  • Indirect population

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Few studies.

9. Assessment of the statistical interpretation

Moderate effect.

10. Relevance to the specific claim

Supports C-SOD-05 (with limitations).

11. Independent contrary findings

None.

12. Transferability to Germany and Europe

Moderate.

13. Overall methodological judgement

Low-certainty support.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Other populations.

15. Linked fact checks